← Leaderboards
Greg A. Gerhardt
University Of Kentucky
$11,382,922
Attributed
$12,365,999
Total exposure
15
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,220,714 · 16
By mechanism
P50$12,607,863 · 5
R01$5,811,577 · 5
RF1$2,050,582 · 1
T32$1,010,448 · 1
R21$651,185 · 2
K02$582,665 · 1
Top collaborators
- Jorge E Quintero2 shared
- John T. Slevin2 shared
- Craig Van Horne2 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- John A Stanford$3,858,416
- Zhiming Zhang$5,043,972
- Frederick C De Beer$6,226,764
- Don Marshall Gash$3,828,081
- Lee Xenakis Blonder$1,437,702
Others in their field
Top investigators on “Laboratory Rat”
- Barney Sparrow · Battelle Memorial Institute$68,853,027
- Richard A Gibbs · Baylor College Of Medicine$59,652,654
- Howard J Jacob · Medical College Of Wisconsin$35,611,302
- David Heimbrook · Leidos Biomedical Research, Inc.$26,424,278
- Milton D Hejtmancik · Battelle Centers/Pub Hlth Res & Evaluatn$24,972,057
- Charles Hebert · Southern Research Institute$24,146,988
Research focus
Laboratory RatDopamineAgingMicrodialysisHippocampusNeurochemistryGlutamatesMicroelectrodesParkinson'S DiseaseNeuronsNeurotrophic FactorsIn VivoAffectNicotineNeuropharmacologyNicotinic ReceptorsMacaca MulattaNitric OxideSchizophreniaAnimalsAcetylcholineElectrochemistryAlzheimer&AposNervous System Regeneration
Grant awards (59)
Phase I Cell Therapy for Maintaining Cholinergic Circuits in the Spectrum of Alzheimerâs Disease$651,202
R01 · FY2025 · AG · contact PI
Dynamic GABA and Glutamate Neurotransmission in Alzheimerâs Disease and Aging$649,861
R01 · FY2025 · AG · contact PI
Dynamic GABA and Glutamate Neurotransmission in Alzheimerâs Disease and Aging$663,123
R01 · FY2024 · AG · contact PI
Phase I Cell Therapy for Maintaining Cholinergic Circuits in the Spectrum of Alzheimerâs Disease$659,568
R01 · FY2024 · AG · contact PI
Dynamic GABA and Glutamate Neurotransmission in Alzheimerâs Disease and Aging$2,050,582
RF1 · FY2021 · AG · contact PI
Tonic and Phasic Glutamate Release from Psychomotor Stimulants$178,200
R21 · FY2013 · DA · contact PI
Cellular and Molecular Basis of Brain Aging$26,384
T32 · FY2013 · AG · contact PI
Cellular and Molecular Basis of Brain Aging$248,916
T32 · FY2012 · AG · contact PI
Tonic and Phasic Glutamate Release from Psychomotor Stimulants$185,625
R21 · FY2012 · DA · contact PI
Cellular and Molecular Basis of Brain Aging$253,931
T32 · FY2011 · AG · contact PI
Cellular and Molecular Basis of Brain Aging$246,557
T32 · FY2010 · AG · contact PI
Restoration of Dopaminergic Function in Parkinson's Disease$1,153,440
P50 · FY2009 · NS · contact PI
Neuropharmacological Studies$281,962
P50 · FY2009 · NS · contact PI
Cellular and Molecular Basis of Brain Aging$234,660
T32 · FY2009 · AG · contact PI
Restoration of Dopaminergic Function in Parkinson's Disease$1,120,083
P50 · FY2008 · NS · contact PI
Neuropharmacological Studies$273,805
P50 · FY2008 · NS · contact PI
Restoration of Dopaminergic Function in Parkinson's Disease$1,186,609
P50 · FY2007 · NS · contact PI
Neurochem Chip: Methodology to Study Untethered Rats$411,662
R01 · FY2007 · DA · contact PI
Neuropharmacological Studies$272,494
P50 · FY2007 · NS · contact PI
NEUROCHEMICAL STUDIES OF THE AGING BASAL GANGLIA$172,608
P01 · FY2007 · AG · contact PI
Restoration of Dopaminergic Function in Parkinson's Disease$1,186,700
P50 · FY2006 · NS · contact PI
Neurochem Chip: Methodology to Study Untethered Rats$411,631
R01 · FY2006 · DA · contact PI
Neuropharmacological Studies$250,673
P50 · FY2006 · NS · contact PI
NEUROCHEMICAL STUDIES OF THE AGING BASAL GANGLIA$148,073
P01 · FY2006 · AG · contact PI
Restoration of Dopaminergic Function in Parkinson's Disease$61,530
P50 · FY2006 · NS · contact PI
Restoration of Dopaminergic Function in Parkinson's Disease$1,150,900
P50 · FY2005 · NS
Neurochem Chip: Methodology to Study Untethered Rats$409,285
R01 · FY2005 · DA
Neuropharmacological Studies$243,655
P50 · FY2005 · NS
Administrative Core$92,630
P50 · FY2005 · NS
RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE$43,583
P50 · FY2005 · NS
RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE$734,088
P50 · FY2004 · NS
Neurochem Chip: Methodology to Study Untethered Rats$361,140
R01 · FY2004 · DA
NITRIC OXIDE AND CHOLINERGIC MECHANISMS IN SCHIZOPHRENIA$116,533
K02 · FY2004 · MH
RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE$1,099,653
P50 · FY2003 · NS
Neurochem Chip: Methodology to Study Untethered Rats$411,341
R01 · FY2003 · DA
NITRIC OXIDE AND CHOLINERGIC ACTIVITY IN SCHIZOPHRENIA$178,709
R01 · FY2003 · MH
NITRIC OXIDE AND CHOLINERGIC MECHANISMS IN SCHIZOPHRENIA$116,533
K02 · FY2003 · MH
RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE$1,070,801
P50 · FY2002 · NS
NITRIC OXIDE AND CHOLINERGIC ACTIVITY IN SCHIZOPHRENIA$173,503
R01 · FY2002 · MH
AGE INDUCED CHANGES IN MONOAMINE PRESYNAPTIC FUNCTION$171,045
R01 · FY2002 · AG
Neurochem Chip: Study of Neurotransmitter Release$142,560
R21 · FY2002 · DA
NITRIC OXIDE AND CHOLINERGIC MECHANISMS IN SCHIZOPHRENIA$116,533
K02 · FY2002 · MH
Quantitative neurochemical studies of effects of chronic delivery of GDNF$0
P50 · FY2002 · NS
Core--Teaching and training$0
P50 · FY2002 · NS
RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE$1,042,796
P50 · FY2001 · NS
NITRIC OXIDE AND CHOLINERGIC ACTIVITY IN SCHIZOPHRENIA$168,450
R01 · FY2001 · MH
AGE INDUCED CHANGES IN MONOAMINE PRESYNAPTIC FUNCTION$166,064
R01 · FY2001 · AG
Neurochem Chip: Study of Neurotransmitter Release$144,800
R21 · FY2001 · DA
NITRIC OXIDE AND CHOLINERGIC MECHANISMS IN SCHIZOPHRENIA$116,533
K02 · FY2001 · MH
Core--Teaching and training$0
P50 · FY2001 · NS
Quantitative neurochemical studies of effects of chronic delivery of GDNF$0
P50 · FY2001 · NS
AGE RELATED DECLINES IN MOVEMENT FUNCTIONS IN RHESUS MONKEYS$0
P01 · FY2001 · AG
RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE$1,004,532
P50 · FY2000 · NS
AGE RELATED DECLINES IN MOVEMENT FUNCTIONS IN RHESUS MONKEYS$185,713
P01 · FY2000 · AG
Quantitative neurochemical studies of effects of chronic delivery of GDNF$168,965
P50 · FY2000 · NS
Core--Teaching and training$168,964
P50 · FY2000 · NS
NITRIC OXIDE AND CHOLINERGIC ACTIVITY IN SCHIZOPHRENIA$163,543
R01 · FY2000 · MH
AGE INDUCED CHANGES IN MONOAMINE PRESYNAPTIC FUNCTION$161,450
R01 · FY2000 · AG
NITRIC OXIDE AND CHOLINERGIC MECHANISMS IN SCHIZOPHRENIA$116,533
K02 · FY2000 · MH